Loreta P. Ciuffreda
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium.
Journal: Pharmacological research
Published: December 31, 2019
Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity.
Journal: Scientific reports
Published: November 28, 2019
Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension.
Journal: Oxidative medicine and cellular longevity
Published: August 02, 2018
Lung Mesenchymal Stem Cells Ameliorate Elastase-Induced Damage in an Animal Model of Emphysema.
Journal: Stem cells international
Published: August 03, 2017
Upregulation of TH/IL-17 Pathway-Related Genes in Human Coronary Endothelial Cells Stimulated with Serum of Patients with Acute Coronary Syndromes.
Journal: Frontiers in cardiovascular medicine
Published: November 08, 2016
Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction.
Journal: British journal of pharmacology
Published: August 04, 2016
Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction.
Journal: British journal of pharmacology
Published: July 19, 2016
Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction.
Journal: International journal of cardiology
Published: February 19, 2016
Doxorubicin cardiotoxicity and target cells: a broader perspective.
Journal: Cardio-oncology (London, England)
Published: February 08, 2016
SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy.
Journal: International journal of cardiology
Published: August 04, 2015
Last Updated: 09/26/2026